Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquarello

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.
Elife|June 23, 2020
A divergent cyclin/cyclin-dependent kinase complex controls the atypical replication of a malaria parasite during gametogony and transmissionAurélia C Balestra, Mohammad Zeeshan, Edward Rea, et al.
Journal of Proteomics|May 19, 2015
Multicenter experiment for quality control of peptide-centric LC-MS/MS analysis - A longitudinal performance assessment with nLC coupled to orbitrap MS analyzersAlex Campos, Ramón Díaz, Salvador Martínez-Bartolomé, et al.
Science Advances|March 25, 2021
Ca<sup>2+</sup> signals critical for egress and gametogenesis in malaria parasites depend on a multipass membrane protein that interacts with PKGAurélia C Balestra, Konstantinos Koussis, Natacha Klages, et al.
Journal of Medicinal Chemistry|July 2, 2010
Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.
Chemmedchem|November 15, 2007
Heteroaryl-substituted 4-(1H-pyrazol-1-yl)-5,6-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives as potent and selective corticotropin-releasing factor receptor-1 antagonistsFabio Maria Sabbatini, Romano Di Fabio, Yves St-Denis, et al.
Blood|December 4, 2004
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIEnrico Tiacci, Pier-Luigi Orvietani, Barbara Bigerna, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 12, 2011
QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materialsPaolo Giannozzi, Stefano Baroni, Nicola Bonini, et al.
Nature|March 18, 2026
Triple-junction solar cells with improved carrier and photon managementKerem Artuk, Deniz Turkay, Austin Kuba, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxietyY St-Denis, R Di Fabio, G Bernasconi, et al.
Elife|June 23, 2020
A divergent cyclin/cyclin-dependent kinase complex controls the atypical replication of a malaria parasite during gametogony and transmissionAurélia C Balestra, Mohammad Zeeshan, Edward Rea, et al.
Journal of Proteomics|May 19, 2015
Multicenter experiment for quality control of peptide-centric LC-MS/MS analysis - A longitudinal performance assessment with nLC coupled to orbitrap MS analyzersAlex Campos, Ramón Díaz, Salvador Martínez-Bartolomé, et al.
Science Advances|March 25, 2021
Ca<sup>2+</sup> signals critical for egress and gametogenesis in malaria parasites depend on a multipass membrane protein that interacts with PKGAurélia C Balestra, Konstantinos Koussis, Natacha Klages, et al.
Journal of Medicinal Chemistry|July 2, 2010
Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.
Chemmedchem|November 15, 2007
Heteroaryl-substituted 4-(1H-pyrazol-1-yl)-5,6-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives as potent and selective corticotropin-releasing factor receptor-1 antagonistsFabio Maria Sabbatini, Romano Di Fabio, Yves St-Denis, et al.
Blood|December 4, 2004
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIEnrico Tiacci, Pier-Luigi Orvietani, Barbara Bigerna, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|August 12, 2011
QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materialsPaolo Giannozzi, Stefano Baroni, Nicola Bonini, et al.
Nature|March 18, 2026
Triple-junction solar cells with improved carrier and photon managementKerem Artuk, Deniz Turkay, Austin Kuba, et al.
Pageof 16